| Sanofi-Aventis (Suisse) SA - Dupixent 200 mg/ 1.14 ml, Injektionslösung im Fertigpen |
| 67661 | | 01 | | Dupixent 200 mg/ 1.14 ml | | Injektionslösung im Fertigpen | | D11AH05 | | Dupilumab | | 04.03.2021 | | |
|
| Composition |
| dupilumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1.14 ml corresp. natrium 0.25 mg. |
| Packungsbestandteile |
| solution injectable en stylo pré-rempli | | | | | | | | Active Agent | Dose |
|---|
| Dupilumabum | 200mg / 1.14ml |
| | BAG: Active Agent | Dose |
|---|
| Dupilumabum | 200 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Natrii Acetas Trihydricus | | Polysorbatum 80 | | Saccharum |
| |
|
|
